Publication: 401

Publication: 401

Adjuvant mFOLFOX6 +/- Cetuxiumab in KRAS Wild Type Patients With Resected Stage III Colon Cancer: NCCTG Intergroup Phase III Trial N0147.

URL

Google Scholar

Citation:: J Clin Oncol vol 28 (18s) abstr CRA3507

Meeting Instance:: ASCO 2010
Year:: 2010
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 477 2594

Program:: OGC
Primary Committee:: GI
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: S. R. Alberts D. J. Sargent T. C. Smyrk A. F. Shields E. Chan R. M. Goldberg S. Gill M. S. Kahlenberg S. N. Thibodeau S. Nair

Networks:

Study: NCCTG-N0147
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: